Skip to main content
BMC Pharmacology logoLink to BMC Pharmacology
. 2009 Aug 11;9(Suppl 1):S25. doi: 10.1186/1471-2210-9-S1-S25

Presynaptic cGMP-dependent protein kinase-I mediates synaptic potentiation in spinal amplification of pain

Ceng Luo 1, Rohini Kuner 1,
PMCID: PMC3313416

Background

Activity-dependent facilitation of pain is functionally linked to plasticity at synapses between peripheral sensory afferents and spinal projection neurons. However, the underlying cellular and molecular mechanisms are not well-understood [1]. We observed that long-term potentiation at these synapses involves a presynaptic mechanism comprising activity-induced decrease in synaptic failures. This process involves activation of the cGMP-dependent protein kinase-I (PKG-I) in presynaptic terminals of nociceptive afferents and potentiation of vesicular transmitter release via modulation of IP3 receptors and myosin light chains. Mice lacking PKG-I specifically in nociceptors did not develop spinal long-term potentiation and showed marked defects in pathological pain in vivo.

Conclusion

Our results reveal a causal link between PKG-I-dependent presynaptic modulation of transmitter release, long-term potentiation at spinal synapses and the induction of pathological pain.

References

  1. Woolf CJ, Salter MW. Neuronal plasticity: Increasing the gain in pain. Science. 2000;288:1765–1768. doi: 10.1126/science.288.5472.1765. [DOI] [PubMed] [Google Scholar]

Articles from BMC Pharmacology are provided here courtesy of BMC

RESOURCES